Notch信号通路介导免疫炎症反应参与肝损伤的作用机制
DOI: 10.12449/JCH251134
利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:黄英、张衎、何发娟、龙富立参与修改论文;舒发明、毛德文负责设计论文框架,起草论文,并对文章进行修改,终审论文。
Mechanism of action of the Notch signaling pathway in mediating immune inflammatory response in liver injury
-
摘要: 免疫炎症反应贯穿于肝损伤的整个病理过程,然而其具体调控机制尚未完全阐明。近年研究发现,Notch信号通路通过调控巨噬细胞极化、中性粒细胞募集活化及调节性免疫细胞分化等方式,在肝损伤中发挥重要作用。本文系统梳理了Notch信号通路介导免疫炎症反应参与肝损伤的分子机制并总结归纳,旨在为肝脏疾病免疫炎症损伤分子机制的阐明提供新视角,并为未来研究方向提供新的参考。Abstract: Immune inflammatory response runs through the whole pathological process of liver injury, but its specific regulatory mechanism remains unclear. Recent studies have shown that the Notch signaling pathway plays an important role in liver injury by regulating macrophage polarization, activating neutrophil recruitment, and modulating the differentiation of regulatory immune cells. This article systematically reviews the molecular mechanisms of the Notch signaling pathway in mediating immune inflammatory response in liver injury, in order to provide new perspectives for clarifying the molecular mechanism of immune inflammatory damage in liver diseases, as well as a new reference for future research directions.
-
Key words:
- Liver Injury /
- Receptors, Notch /
- Pathologic Processes
-
[1] LI BL, XU LH. Differential diagnosis of drug-induced liver injury, drug-induced autoimmune hepatitis and autoimmune hepatitis[J]. J Pract Hepatol, 2021, 24( 4): 460- 463. DOI: 10.3969/j.issn.1672-5069.2021.04.002.李变利, 徐丽红. 药物性肝损伤、药物诱导性自身免疫性肝炎和自身免疫性肝炎鉴别诊断研究进展[J]. 实用肝脏病杂志, 2021, 24( 4): 460- 463. DOI: 10.3969/j.issn.1672-5069.2021.04.002. [2] LI F, WANG S. An excerpt of EASL clinical practice guideline: Occupational liver diseases(2019)[J]. J Clin Hepatol, 2020, 36( 2): 293- 298. DOI: 10.3969/j.issn.1001-5256.2020.02.008.李帆, 王帅.《2019年欧洲肝病学会临床实践指南: 职业性肝病》摘译[J]. 临床肝胆病杂志, 2020, 36( 2): 293- 298. DOI: 10.3969/j.issn.1001-5256.2020.02.008. [3] SHANG DB, XIANG XG. Advances in the pathogenesis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37( 4): 765- 769. DOI: 10.3969/j.issn.1001-5256.2021.04.005.尚大宝, 项晓刚. 慢加急性肝衰竭的发病机制和治疗进展[J]. 临床肝胆病杂志, 2021, 37( 4): 765- 769. DOI: 10.3969/j.issn.1001-5256.2021.04.005. [4] LIU SQ, YANG JZ, YANG T, et al. Expert consensus on emergency diagnosis and treatment of adult acute liver injury[J]. Chin J Crit Care Med, 2024, 44( 1): 5- 12. DOI: 10.3969/j.issn.1002-1949.2024.01.002.刘双庆, 杨建中, 杨婷, 等. 成人急性肝损伤诊疗急诊专家共识[J]. 中国急救医学, 2024, 44( 1): 5- 12. DOI: 10.3969/j.issn.1002-1949.2024.01.002. [5] ALQAHTANI SA, KLEINER DE, GHABRIL M, et al. Identification and characterization of cefazolin-induced liver injury[J]. Clin Gastroenterol Hepatol, 2015, 13( 7): 1328- 1336. e 2. DOI: 10.1016/j.cgh.2014.11.036. [6] Chinese Association of Integrative Medicine, China Association of Chinese Medicine, Chinese Medical Association. Guidelines for the integrated traditional Chinese and Western medicine diagnosis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2023, 39( 7): 1547- 1552. DOI: 10.3969/j.issn.1001-5256.2023.07.006.中国中西医结合学会, 中华中医药学会, 中华医学会. 慢加急性肝衰竭中西医结合诊疗指南[J]. 临床肝胆病杂志, 2023, 39( 7): 1547- 1552. DOI: 10.3969/j.issn.1001-5256.2023.07.006. [7] WEI Q, LI L, ZENG XQ, et al. An analysis on the clinical features and risk factors associated with the prognosis of patients with drug-induced liver injury[J]. Explor Dig Dis, 2023: 100- 117. DOI: 10.37349/edd.2023.00021. [8] ZUO J, FAN YC. Progress in immunologic injury mechanism of hepatitis B virus-related acute-on-chronic liver failure[J]. J Crit Care Intern Med, 2024, 30( 3): 193- 199. DOI: 10.11768/nkjwzzzz20240301.左静, 范玉琛. 乙型肝炎相关慢加急性肝衰竭免疫损伤机制研究进展[J]. 内科急危重症杂志, 2024, 30( 3): 193- 199. DOI: 10.11768/nkjwzzzz2024-0301. [9] DONNELLY MC, HAYES PC, SIMPSON KJ. Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy[J]. World J Gastroenterol, 2016, 22( 26): 5958- 5970. DOI: 10.3748/wjg.v22.i26.5958. [10] ZHANG N, YAN N, ZHOU ME, et al. Development and treatment of NLRP3 inflammatory corpuscule in acute and chronic liver diseases[J]. Liaoning J Tradit Chin Med, 2020, 47( 5): 217- 220. DOI: 10.13192/j.issn.1000-1719.2020.05.065.张娜, 晏旎, 周蒙恩, 等. NLRP3炎症小体在急慢性肝脏疾病发生和治疗中的研究进展[J]. 辽宁中医杂志, 2020, 47( 5): 217- 220. DOI: 10.13192/j.issn.1000-1719.2020.05.065. [11] WANG TS, WANG N, ZHANG RZ, et al. Role of immune response and inflammatory injury in the pathogenesis of liver failure[J]. J Clin Hepatol, 2020, 36( 6): 1415- 1419. DOI: 10.3969/j.issn.1001-5256.2020.06.050.王挺帅, 王娜, 张荣臻, 等. 免疫反应与炎症损伤在肝衰竭发病机制中的作用[J]. 临床肝胆病杂志, 2020, 36( 6): 1415- 1419. DOI: 10.3969/j.issn.1001-5256.2020.06.050. [12] WEI SS, MA WJ, ZHANG BK, et al. NLRP3 inflammasome: A promising therapeutic target for drug-induced toxicity[J]. Front Cell Dev Biol, 2021, 9: 634607. DOI: 10.3389/fcell.2021.634607. [13] LIU J, LUO RY, ZHANG YH, et al. Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury[J]. Clin Mol Hepatol, 2024, 30( 4): 585- 619. DOI: 10.3350/cmh.2024.0222. [14] YANG T, QU XY, ZHAO JY, et al. Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury[J]. Cell Commun Signal, 2023, 21( 1): 160. DOI: 10.1186/s12964-023-01175-4. [15] CHRISTOPOULOS PF, GJØLBERG TT, KRÜGER S, et al. Targeting the Notch signaling pathway in chronic inflammatory diseases[J]. Front Immunol, 2021, 12: 668207. DOI: 10.3389/fimmu.2021.668207. [16] GALLENSTEIN N, TICHY L, WEIGAND MA, et al. Notch signaling in acute inflammation and sepsis[J]. Int J Mol Sci, 2023, 24( 4): 3458. DOI: 10.3390/ijms24043458. [17] LÓPEZ-LÓPEZ S, MONSALVE EM, ROMERO DE ÁVILA MJ, et al. NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages[J]. Sci Rep, 2020, 10( 1): 14839. DOI: 10.1038/s41598-020-71810-4. [18] SUN JC, CHEN Y, XU ZY, et al. Notch signaling in the tumor immune microenvironment of colorectal cancer: Mechanisms and therapeutic opportunities[J]. J Transl Med, 2025, 23( 1): 315. DOI: 10.1186/s12967-025-06282-z. [19] SHAO MJ, TIAN T, LUO JY, et al. Role of the NOTCH signaling pathway in cardiovascular diseases[J]. Chin J Heart Fail Cardiomyopathy, 2021, 5( 4): 275- 281. DOI: 10.3760/cma.j.cn101460-20201108-00113.邵梦娇, 田婷, 罗俊一, 等. NOTCH信号通路在心血管疾病中的作用[J]. 中华心力衰竭和心肌病杂志, 2021, 5( 4): 275- 281. DOI: 10.3760/cma.j.cn101460-20201108-00113. [20] WANG C, MA C, GONG LH, et al. Macrophage polarization and its role in liver disease[J]. Front Immunol, 2021, 12: 803037. DOI: 10.3389/fimmu.2021.803037. [21] CHEN WY, LIU YN, CHEN J, et al. The Notch signaling pathway regulates macrophage polarization in liver diseases[J]. Int Immunopharmacol, 2021, 99: 107938. DOI: 10.1016/j.intimp.2021.107938. [22] KEEWAN E, NASER SA. The role of Notch signaling in macrophages during inflammation and infection: Implication in rheumatoid arthritis[J]. Cells, 2020, 9( 1): 111. DOI: 10.3390/cells9010111. [23] TAN H, XU WJ, DING XQ, et al. Notch/NICD/RBP-J signaling axis regulates M1 polarization of macrophages mediated by advanced glycation end products[J]. Glycoconj J, 2022, 39( 4): 487- 497. DOI: 10.1007/s10719-022-10062-y. [24] AN N, YANG JX, WANG HQ, et al. Mechanism of mesenchymal stem cells in spinal cord injury repair through macrophage polarization[J]. Cell Biosci, 2021, 11( 1): 41. DOI: 10.1186/s13578-021-00554-z. [25] DUAN MY, LIU XG, YANG Y, et al. Orchestrated regulation of immune inflammation with cell therapy in pediatric acute liver injury[J]. Front Immunol, 2023, 14: 1194588. DOI: 10.3389/fimmu.2023.1194588. [26] CAO W, ZHAO CY, WANG W, et al. Role of the Notch signaling pathway in development of acute liver failure in a mouse model[J]. Chin J Hepatol, 2015, 23( 10): 765- 770. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.011.曹伟, 赵彩彦, 王玮, 等. Notch信号通路在小鼠急性肝衰竭发生发展中的作用[J]. 中华肝脏病杂志, 2015, 23( 10): 765- 770. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.011. [27] KACHANOVA O, LOBOV A, MALASHICHEVA A. The role of the Notch signaling pathway in recovery of cardiac function after myocardial infarction[J]. Int J Mol Sci, 2022, 23( 20): 12509. DOI: 10.3390/ijms23-2012509. [28] ZHANG PR. Endothelial Notch signaling regulates neutrophil transmigration via downregulating endomucin during hepatic ischemia/reperfusion injury[D]. Xi'an: Air Force Medical University of PLA, 2020.张沛然. 内皮细胞Notch信号通过endomucin参与肝脏缺血再灌注损伤中炎细胞招募的机制研究[D]. 西安: 中国人民解放军空军军医大学, 2020. [29] BANSAL R, VAN BAARLEN J, STORM G, et al. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis[J]. Sci Rep, 2015, 5: 18272. DOI: 10.1038/srep18272. [30] CHEN YH, YANG LH, LI XH. Advances in Mesenchymal stem cells regulating macrophage polarization and treatment of sepsis-induced liver injury[J]. Front Immunol, 2023, 14: 1238972. DOI: 10.3389/fimmu.2023.1238972. [31] CAPPENBERG A, KARDELL M, ZARBOCK A. Selectin-mediated signaling: Shedding light on the regulation of integrin activity in neutrophils[J]. Cells, 2022, 11( 8): 1310. DOI: 10.3390/cells11081310. [32] ZHANG K, AI WB, LIU CB, et al. Progress in understanding the relationship between Notch signaling pathway and hepatic stellate cell activation[J]. World Chin J Dig, 2013, 33: 3611- 3616.张凯, 艾文兵, 柳长柏, 等. Notch信号通路与HSC活化关系的研究进展[J]. 世界华人消化杂志, 2013, 33: 3611- 3616. [33] LIU ZY, LI WL, CAO Y, et al. Effects of the interaction of Notch and TLR4 pathways on inflammation and heart function in septic heart[J]. Open Life Sci, 2022, 17( 1): 744- 755. DOI: 10.1515/biol-2022-0076. [34] WANG L, ZHAO XP, XIE JJ, et al. The role of Hippo-YAP/TAZ and Notch signaling pathway in liver fibrosis[J]. Chem Life, 2023, 43( 3): 402- 407. DOI: 10.13488/j.smhx.20230140.王莉, 赵秀萍, 谢娇娇, 等. Hippo-YAP/TAZ与Notch信号通路在肝纤维化中的作用[J]. 生命的化学, 2023, 43( 3): 402- 407. DOI: 10.13488/j.smhx.20230140. [35] WEI X, WANG JP, HAO CQ, et al. Notch signaling contributes to liver inflammation by regulation of interleukin-22-producing cells in hepatitis B virus infection[J]. Front Cell Infect Microbiol, 2016, 6: 132. DOI: 10.3389/fcimb.2016.00132. [36] YOU J, ZHUANG L, MA YL, et al. Research advances in the imbalance of helper T lymphocyte subpopulations and cytokine network in patients with chronic hepatitis B[J]. World Chin J Dig, 2007, 15( 8): 791- 799. DOI: 10.3969/j.issn.1009-3079.2007.08.001.游晶, 庄林, 马永良, 等. 慢性乙型肝炎的Th细胞亚群及相关细胞因子网络失衡[J]. 世界华人消化杂志, 2007, 15( 8): 791- 799. DOI: 10.3969/j.issn.1009-3079.2007.08.001. [37] HU YQ, WU QG, WANG YL, et al. The molecular pathogenesis of triptolide-induced hepatotoxicity[J]. Front Pharmacol, 2022, 13: 979307. DOI: 10.3389/fphar.2022.979307. [38] ZHU YJ. Study on the regulatory effect of MDSCs on T cells in HBV-acute-on-chronic liver failure[D]. Urumqi: Xinjiang Medical University, 2023.朱玥洁. HBV相关慢加急性肝衰竭中MDSCs对T细胞的调节作用研究[D]. 乌鲁木齐: 新疆医科大学, 2023. [39] WANG B, SHEN ML, LI Y, et al. Correlation of Notch1 receptor expression in liver tissue with degree of hepatic fibrosis in patients with chronic hepatitis B[J]. World Chin J Dig, 2017, 25( 28): 2540- 2543. DOI: 10.11569/wcjd.v25.i28.2540.王变, 沈美龙, 李阳, 等. 慢性乙型肝炎患者肝组织Notch-1受体表达与肝纤维化相关性[J]. 世界华人消化杂志, 2017, 25( 28): 2540- 2543. DOI: 10.11569/wcjd.v25.28.2540. [40] DENG J, WANG XF, SUN RQ. Wogonin promotes Th17/Treg cell balance in rat models with autoimmune hepatitis[J]. Basic Clin Med, 2024, 44( 1): 77- 83. DOI: 10.16352/j.issn.1001-6325.2024.01.0077.邓娟, 王秀芳, 孙瑞青. 汉黄芩素促进自身免疫性肝炎模型大鼠Th17/Treg细胞平衡[J]. 基础医学与临床, 2024, 44( 1): 77- 83. DOI: 10.16352/j.issn.1001-6325.2024.01.0077. [41] ADAMS JM, JAFAR-NEJAD H. The roles of Notch signaling in liver development and disease[J]. Biomolecules, 2019, 9( 10): 608. DOI: 10.3390/biom9100608. [42] ZHOU X, WANG Z, HE XR, et al. Research advances in signaling pathways associated with potential anti-liver fibrosis drugs and targets[J]. J Clin Hepatol, 2023, 39( 12): 2932- 2941. DOI: 10.3969/j.issn.1001-5256.2023.12.027.周鑫, 王智, 何雪茹, 等. 潜在抗肝纤维化药物与靶点相关信号通路研究进展[J]. 临床肝胆病杂志, 2023, 39( 12): 2932- 2941. DOI: 10.3969/j.issn.1001-5256.2023.12.027. [43] YU HC, BAI L, YANG ZX, et al. Blocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLD[J]. Sci Rep, 2016, 6: 32226. DOI: 10.1038/srep32226. [44] GAO CC, BAI J, HAN H, et al. The versatility of macrophage heterogeneity in liver fibrosis[J]. Front Immunol, 2022, 13: 968879. DOI: 10.3389/fimmu.2022.968879. [45] MINNIS-LYONS SE, FERREIRA-GONZÁLEZ S, ALEKSIEVA N, et al. Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation[J]. Sci Signal, 2021, 14( 688): eaay9185. DOI: 10.1126/scisignal.aay9185. [46] ZHANG CY, SUN CF, ZHAO YB, et al. Signaling pathways of liver regeneration: Biological mechanisms and implications[J]. iScience, 2023, 27( 1): 108683. DOI: 10.1016/j.isci.2023.108683. [47] XIONG F, ZHANG YC, LI T, et al. A detailed overview of quercetin: Implications for cell death and liver fibrosis mechanisms[J]. Front Pharmacol, 2024, 15: 1389179. DOI: 10.3389/fphar.2024.1389179. -

PDF下载 ( 1828 KB)
下载:
